Clinical Trial Detail

NCT ID NCT03631641
Title Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Joanne Jeter
Indications

colon adenoma

colon cancer

Therapies

Nivolumab

Age Groups: adult senior

Additional content available in CKB BOOST